+ Follow TELMISARTAN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 431369
[Title] => Study shows CVD protection for Pinoys, other Asians
[Summary] => Majority of patients with cardiovascular disease (CVD) leading to heart attack and stroke do not receive appropriate treatment for various reasons.
[DatePublished] => 2009-01-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 424423
[Title] => Filipinos, other Asians benefit from telmisartan
[Summary] => The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) showed very promising results in Asian patients, as well as non-Asian patients, at high risk of cardiovascular disease (CVD).
[DatePublished] => 2008-12-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 416475
[Title] => Heart specialists welcome ARB trial
[Summary] => Local heart specialists welcomed the results of a landmark trial showing that the angiotensin receptor blocker (ARB) telmisartan is as effective as, and better tolerated than, the gold standard angiotensin-converting enzyme (ACE) inhibitor ramipril in reducing the risk of heart attack, stroke and hospitalization for congestive heart failure in high-risk patients.
[DatePublished] => 2008-11-20 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 13157
[Title] => Reducing heart attack, stroke risks
[Summary] =>
[DatePublished] => 2007-08-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 224399
[Title] => Trial seeks optimum hypertension mg’t
[Summary] => The growth in the medical understanding of heart disease that has been achieved with well-designed researches and clinical trials is one of the greatest achievements in medical history. Medical researchers all over the world have slowly but continuously provided the answers to many questions on heart-related diseases.
[DatePublished] => 2003-10-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 221974
[Title] => ONTARGET: Protecting high-risk patients
[Summary] => Medical scientists and researchers are continuously undertaking researches and clinical trials which are answering a lot of previously unanswered questions in modern medicine.
Clinical trials have already convincingly shown that sustained management of hypertension significantly reduces the risk of cardiovascular events such as heart attack, heart failure, stroke and heart-related deaths.
Among the most effective medicines available to physicians is telmisartan, a medicine belonging to the angiotensin II receptor blocker class of drugs.
[DatePublished] => 2003-09-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 220870
[Title] => Stroke risk greatest in the morning
[Summary] => Nicanor woke up one morning to find lack of sensation in his left arm and leg. When he complained to his wife about the numbness, she suggested that Nicanor have his blood pressure checked. He, however, dismissed the idea that his feeling was caused by a high blood pressure. After all, it was early morning and he was well-rested during the night. Thinking that his wife is just overreacting, Nicanor went about his daily routine. When the feeling grew worse, however, his wife decided to take him to the hospital. It was found out that his BP rose to 170/100 mmHg.
[DatePublished] => 2003-09-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 198784
[Title] => New insights in managing hypertension
[Summary] => High blood pressure (BP) remains as a leading cardiovascular problem leading to strokes and heart attacks, and despite advances in its treatment, there is still much to be desired to prevent its dreaded complications.
[DatePublished] => 2003-03-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 153491
[Title] => Combined blood pressure therapy works well
[Summary] => High blood pressure, or hypertension, is the most widespread of all cardiovascular diseases in the world. It is the leading cause of stroke and a major cause of heart attack.
In the United States alone, approximately 40 million people have high blood pressure. In the Philippines, it is estimated that 22 percent of the adult population has high blood pressure, the fifth leading cause of morbidity or illness among Filipinos.
[DatePublished] => 2002-03-11 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
TELMISARTAN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 431369
[Title] => Study shows CVD protection for Pinoys, other Asians
[Summary] => Majority of patients with cardiovascular disease (CVD) leading to heart attack and stroke do not receive appropriate treatment for various reasons.
[DatePublished] => 2009-01-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 424423
[Title] => Filipinos, other Asians benefit from telmisartan
[Summary] => The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) showed very promising results in Asian patients, as well as non-Asian patients, at high risk of cardiovascular disease (CVD).
[DatePublished] => 2008-12-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 416475
[Title] => Heart specialists welcome ARB trial
[Summary] => Local heart specialists welcomed the results of a landmark trial showing that the angiotensin receptor blocker (ARB) telmisartan is as effective as, and better tolerated than, the gold standard angiotensin-converting enzyme (ACE) inhibitor ramipril in reducing the risk of heart attack, stroke and hospitalization for congestive heart failure in high-risk patients.
[DatePublished] => 2008-11-20 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 13157
[Title] => Reducing heart attack, stroke risks
[Summary] =>
[DatePublished] => 2007-08-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 224399
[Title] => Trial seeks optimum hypertension mg’t
[Summary] => The growth in the medical understanding of heart disease that has been achieved with well-designed researches and clinical trials is one of the greatest achievements in medical history. Medical researchers all over the world have slowly but continuously provided the answers to many questions on heart-related diseases.
[DatePublished] => 2003-10-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 221974
[Title] => ONTARGET: Protecting high-risk patients
[Summary] => Medical scientists and researchers are continuously undertaking researches and clinical trials which are answering a lot of previously unanswered questions in modern medicine.
Clinical trials have already convincingly shown that sustained management of hypertension significantly reduces the risk of cardiovascular events such as heart attack, heart failure, stroke and heart-related deaths.
Among the most effective medicines available to physicians is telmisartan, a medicine belonging to the angiotensin II receptor blocker class of drugs.
[DatePublished] => 2003-09-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 220870
[Title] => Stroke risk greatest in the morning
[Summary] => Nicanor woke up one morning to find lack of sensation in his left arm and leg. When he complained to his wife about the numbness, she suggested that Nicanor have his blood pressure checked. He, however, dismissed the idea that his feeling was caused by a high blood pressure. After all, it was early morning and he was well-rested during the night. Thinking that his wife is just overreacting, Nicanor went about his daily routine. When the feeling grew worse, however, his wife decided to take him to the hospital. It was found out that his BP rose to 170/100 mmHg.
[DatePublished] => 2003-09-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 198784
[Title] => New insights in managing hypertension
[Summary] => High blood pressure (BP) remains as a leading cardiovascular problem leading to strokes and heart attacks, and despite advances in its treatment, there is still much to be desired to prevent its dreaded complications.
[DatePublished] => 2003-03-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 153491
[Title] => Combined blood pressure therapy works well
[Summary] => High blood pressure, or hypertension, is the most widespread of all cardiovascular diseases in the world. It is the leading cause of stroke and a major cause of heart attack.
In the United States alone, approximately 40 million people have high blood pressure. In the Philippines, it is estimated that 22 percent of the adult population has high blood pressure, the fifth leading cause of morbidity or illness among Filipinos.
[DatePublished] => 2002-03-11 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
January 15, 2009 - 12:00am
December 18, 2008 - 12:00am
November 20, 2008 - 12:00am
August 16, 2007 - 12:00am
October 16, 2003 - 12:00am
September 25, 2003 - 12:00am
September 18, 2003 - 12:00am
